In the media
February 16, 2022
On BBC Radio 5 Live, Owkin co-founder and CEO Thomas Clozel explains our new AI project to better detect HER2-positive breast cancer
Today our co-founder and CEO Thomas Clozel joined Naga Munchetty on B Radio to discuss our new project to develop hashtag#AI models to better detect HER2-positive breast cancer in women.
Share to:
About Owkin
Owkin is an agentic AI company on a mission to explore complex biology to speed up and scale research for the creation of new treatments and diagnostics for patients. Owkin K, our AI co-pilot combines unparalleled access to multimodal data, cutting-edge AI to quantify biology and pioneering agentic AI to achieve Biological Artificial Superintelligence in the future.
